Xenon Pharmaceuticals Inc (XENE)
Stock-Based Compensation
$61.45M
TTM · Period ending: · USD
XENE Stock-Based Compensation
Latest reported$61.45Mperiod ending
Latest reported$61.45Mperiod ending
XENE Stock-Based Comp ($447.00K → $61.45M)
Annual stock-based compensation
High-resolution chart · PNG
XENE stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 53,707,000 | |
| 50,717,000 | |
| 32,372,000 | |
| 20,376,000 | |
| 10,017,000 | |
| 5,677,000 | |
| 2,924,000 | |
| 2,625,000 | |
| 2,236,000 | |
| 2,161,000 | |
| 3,729,000 | |
| 760,000 | |
| 648,000 | |
| 414,000 | |
| 447,000 |